Djibouti Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Djibouti Health Journal.

Press releases published on April 20, 2026

Apr. 20, 2026

Max Immunity Clinic Opens in Markham, Offering Regenerative and Recovery-Based Therapies

Indeterminate GlobeNewswire

Apr. 20, 2026

Atsena Therapeutics Receives Data Monitoring Committee Recommendation to Proceed with Pivotal Part C Cohort of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis

Indeterminate GlobeNewswire

Apr. 20, 2026

Kyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable Responses through 52 Weeks

Indeterminate GlobeNewswire

Apr. 20, 2026

Tenvie Therapeutics Announces Dosing of First Subject in Phase 1 Clinical Trial of TNV108, an Allosteric SARM1 inhibitor

Indeterminate GlobeNewswire

Apr. 20, 2026

BVI gibt bekannt, dass Virtuoso®, eine neue chirurgische Plattform mit Doppelfunktion, die CE-Kennzeichnung gemäß EU-MDR erhalten hat

Indeterminate GlobeNewswire

Apr. 20, 2026

LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency for VIZZ® for the Treatment of Presbyopia in the United Kingdom

Indeterminate GlobeNewswire

Apr. 20, 2026

BVI annonce l’obtention du marquage CE au titre du Règlement européen sur les dispositifs médicaux pour Virtuoso®, une toute nouvelle plateforme chirurgicale à double fonction

Indeterminate GlobeNewswire

Apr. 20, 2026

Calidi Biotherapeutics Presents New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026

Indeterminate GlobeNewswire

Apr. 20, 2026

BioCardia and Japan PMDA Align on Acceptability of CardiAMP Clinical Data to Support Regulatory Approval in Ischemic Heart Failure

Indeterminate GlobeNewswire

Apr. 20, 2026

Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer

Indeterminate GlobeNewswire

Apr. 20, 2026

Standard Dental Labs Inc. Appoints Brendan Cummins to Board of Directors

Indeterminate GlobeNewswire

Apr. 20, 2026

Phathom Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, April 30, 2026

Indeterminate GlobeNewswire

Apr. 20, 2026

Nanox Announces Fourth Quarter of 2025 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

Apr. 20, 2026

Axe Compute Unveils Compute Reserve Dashboard, Giving Investors a Unified View of Its NASDAQ Stock and Operational Strategic Compute Reserve

Indeterminate GlobeNewswire

Apr. 20, 2026

AskBio's Viralgen to Supply Commercial-Scale Drug Product for REGENERATE-PD Investigational Gene Therapy Phase II Trial for Parkinson’s Disease

Indeterminate GlobeNewswire

Apr. 20, 2026

Helus Pharma Announces Chief Executive Officer Transition; Eric So to Resume Role as Interim Chief Executive Officer

Indeterminate GlobeNewswire

Apr. 20, 2026

Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile

Indeterminate GlobeNewswire

Apr. 20, 2026

Psyence BioMed Positioned as World's only Licensed Pharmaceutical Grade Ibogaine Supplier at Source

Indeterminate GlobeNewswire

Apr. 20, 2026

NewcelX Updates Corporate Presentation to Highlight Type 1 Diabetes Flagship Program Following Strategic Collaboration with Eledon Pharmaceuticals Ahead of Swiss Biotech Conference

Indeterminate GlobeNewswire

Apr. 20, 2026

Cronos Group Inc. to Hold 2026 First Quarter Earnings Conference Call on May 11, 2026

Indeterminate GlobeNewswire